Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer

Current Cancer Drug Targets

Volumn 8, Issue 3, 2008, Pages 223-229

  Finn, Greg ^a   Kun, Ping Lu ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE PIN1; SERINE; THREONINE; TUMOR MARKER;

BREAST CANCER; CARCINOGENESIS; CATALYSIS; CELL CYCLE; CELL FUNCTION; CELL PROLIFERATION; COLON CANCER; DRUG BINDING; DRUG MECHANISM; HUMAN; ISOMERIZATION; LUNG CANCER; MOLECULE; NONHUMAN; ONCOGENE; ONCOGENE NEU; ONCOGENE RAS; PHOSPHORYLATION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL PROLIFERATION; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; NEOPLASMS; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 43449088839     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800908784293622     Document Type: Review

References (69)

1. Lu, K. P. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 2004, 29, 200-209.
2. Wulf, G.; Finn, G.; Suizu, F.; Lu, K. P. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 2005, 7, 435-441.
3. Lu, P. J.; Zhou, X. Z.; Liou, Y. C.; Noel, J. P.; Lu, K. P. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 2002, 277, 2381-2384.
4. Lu, P. J.; Zhou, X. Z.; Shen, M.; Lu, K. P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999, 283, 1325-1328.
5. Lu, K. P.; Hanes, S. D.; Hunter, T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380, 544-547.
6. Pastorino, L.; Sun, A.; Lu, P. J.; Zhou, X. Z.; Balastik, M.; Finn, G.; Wulf, G.; Lim, J.; Li, S. H.; Li, X.; Xia, W.; Nicholson, L. K.; Lu, K. P. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006, 440, 528-534.
7. Zhou, X. Z.; Lu, P. J.; Wulf, G.; Lu, K. P. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism. Cell Mol. Life Sci. 1999, 56, 788-806.
8. Zhou, X. Z.; Kops, O.; Werner, A.; Lu, P. J.; Shen, M.; Stoller, G.; Küllertz, G.; Stark, M.; Fischer, G.; Lu, K. P. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 2000, 6, 873-883.
9. Landrieu, I.; Smet, C.; Wieruszeski, J. M.; Sambo, A. V.; Wintjens, R.; Buée, L.; Lippens, G. Exploring the molecular function of PIN1 by nuclear magnetic resonance. Curr. Protein Pept. Sci. 2006, 7, 179-194.
10. Namanja, A. T.; Peng, T.; Zintsmaster, J. S.; Elson, A. C.; Shakour, M. G.; Peng, J. W. Substrate recognition reduces side-chain flexibility for conserved hydrophobic residues in human Pin1. Structure 2007, 15, 313-327.
11. Lu, K. P.; Suizu, F.; Zhou, X. Z.; Finn, G.; Lam, P.; Wulf, G. Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol. Carcinog. 2006, 45, 397-402.
12. Liou, Y. C.; Ryo, A.; Huang, H. K.; Lu, P. J.; Bronson, R.; Fujimori, F.; Uchida, T.; Hunter, T.; Lu, K. P. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 2002, 99, 1335-1340.
13. Wulf, G. M.; Ryo, A.; Wulf, G. G.; Lee, S. W.; Niu, T.; Petkova, V.; Lu, K. P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001, 20, 3459-3472.
14. Stukenberg, P. T.; Kirschner, M. W. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 2001, 7 , 1071-1083.
15. Bernis, C.; Vigneron, S.; Burgess, A.; Labbé, J. C.; Fesquet, D.; Castro, A.; Lorca, T. Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCF(betatrcp). EMBO Rep. 2007, 8, 91-98.
16. Okamoto, K.; Sagata, N. Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase. Proc. Natl. Acad. Sci. USA 2007, 104, 3753-3758.
17. Shen, M.; Stukenberg, P. T.; Kirschner, M. W.; Lu, K. P. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 1998, 12, 706-720.
18. Xu, Y. X.; Manley, J. L. The prolyl isomerase Pin1 functions in mitotic chromosome condenzation. Mol. Cell 2007, 26, 287-300.
19. Fujimori, F.; Takahashi, K.; Uchida, C.; Uchida, T. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem. Biophys. Res. Commun. 1999, 265, 658-663.
20. You, H.; Zheng, H.; Murray, S. A.; Yu, Q.; Uchida, T.; Fan, D.; Xiao, Z. X. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J. Cell Biochem. 2002, 84, 211-216.
21. Yeh, E.; Cunningham, M.; Arnold, H.; Chasse, D.; Monteith, T.; Ivaldi, G.; Hahn, W. C.; Stukenberg, P. T.; Shenolikar, S.; Uchida, T.; Counter, C. M.; Nevins, J. R.; Means, A. R.; Sears, R. A signaling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 2004, 6, 308-318.
22. Yeh, E. S.; Lew, B. O.; Means, A. R. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J. Biol. Chem. 2006, 281, 241-251.
23. Lu, K. P.; Finn, G.; Lee, T. H.; Nicholson, L. K. Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 2007, 3, 619-629.
24. Lu, K. P. Phosphorylation-dependent prolyl isomerization: a novel cell cycle regulatory mechanism. Prog. Cell Cycle Res. 2000, 4, 83-96.
25. Anderson, P. Pin1: a proline isomerase that makes you wheeze? Nat. Immunol. 2005, 6, 1211-1212.
26. Ryo, A.; Nakamura, M.; Wulf, G.; Liou, Y. C.; Lu, K. P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 2001, 3, 793-801.
27. Bao, L.; Kimzey, A.; Sauter, G.; Sowadski, J. M.; Lu, K. P.; Wang, D. G. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 2004, 164, 1727-1737.
28. Ryo, A.; Liou, Y. C.; Lu, K. P.; Wulf, G. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci. 2003, 116, 773-783.
29. Ayala, G.; Wang, D.; Wulf, G.; Frolov, A.; Li, R.; Sowadski, J.; Wheeler, T. M.; Lu, K. P.; Bao, L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 2003, 63, 6244-6251.
30. Sasaki, T.; Ryo, A.; Uemura, H.; Ishiguro, H.; Inayama, Y.; Yamanaka, S.; Kubota, Y.; Nagashima, Y.; Harada, M.; Aoki, I. An immunohistochemical scoring system of prolyl isomerase Pin1 for predicting relapse of prostate carcinoma after radical prostatectomy. Pathol. Res. Pract. 2006, 202, 357-364.
31. Fukuchi, M.; Fukai, Y.; Kimura, H.; Sohda, M.; Miyazaki, T.; Nakajima, M.; Masuda, N.; Tsukada, K.; Kato, H.; Kuwano, H. Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int. J. Oncol. 2006, 29, 329-334.
32. Miyashita, H.; Uchida, T.; Mori, S.; Echigo, S.; Motegi, K. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins. Oncol. Rep. 2003, 10, 1045-1048.
33. Miyashita, H.; Mori, S.; Motegi, K.; Fukumoto, M.; Uchida, T. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol. Rep. 2003, 10, 455-461.
34. Monje, P.; Hernandez-Losa, J.; Lyons, R. J.; Castellone, M. D.; Gutkind, J. S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 2005, 280, 35081-35084.
35. Ryo, A.; Suizu, F.; Yoshida, Y.; Perrem, K.; Liou, Y. C.; Wulf, G.; Rottapel, R.; Yamaoka, S.; Lu, K. P. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 2003, 12, 1413-1426.
36. Ryo, A.; Liou, Y. C.; Wulf, G.; Nakamura, M.; Lee, S. W.; Lu, K. P. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell Biol. 2002, 22, 5281-5295.
37. Dougherty, M. K.; Müller, J.; Ritt, D. A.; Zhou, M.; Zhou, X. Z.; Copeland, T. D.; Conrads, T. P.; Veenstra, T. D.; Lu, K. P.; Morrison, D. K. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 2005, 17, 215-224.
38. Wulf, G.; Garg, P.; Liou, Y. C.; Iglehart, D.; Lu, K. P. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J. 2004, 23, 3397-3407.
39. Tzahor, E. Wnt/beta-catenin signaling and cardiogenesis: timing does matter. Dev. Cell 2007, 13, 10-13.
40. Pang, R.; Yuen, J.; Yuen, M. F.; Lai, C. L.; Lee, T. K.; Man, K.; Poon, R. T.; Fan, S. T.; Wong, C. M.; Ng, I. O.; Kwong, Y. L.; Tse, E. PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene 2004, 23, 4182-4186.
41. Suizu, F.; Ryo, A.; Wulf, G.; Lim, J.; Lu, K. P. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Mol. Cell Biol. 2006, 26, 1463-1479.
42. Takahashi, K.; Akiyama, H.; Shimazaki, K.; Uchida, C.; Akiyama-Okunuki, H.; Tomita, M.; Fukumoto, M.; Uchida, T. Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Oncogene 2007, 26, 3835-3845.
43. Yi, P.; Wu, R. C.; Sandquist, J.; Wong, J.; Tsai, S. Y.; Tsai, M. J.; Means, A. R.; O'Malley, B. W. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol. Cell Biol. 2005, 25, 9687-9699.
44. Lufei, C.; Koh, T. H.; Uchida, T.; Cao, X. Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene 2007, 26(55), 7656-7664.
45. Mantovani, F.; Gostissa, M.; Collavin, L.; Del Sal, G. KeePin' the p53 family in good shape. Cell Cycle 2004, 3, 905-911.
46. Zacchi, P.; Gostissa, M.; Uchida, T.; Salvagno, C.; Avolio, F.; Volinia, S.; Ronai, Z.; Blandino, G.; Schneider, C.; Del Sal, G. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419, 853-857.
47. Wulf, G. M.; Liou, Y. C.; Ryo, A.; Lee, S. W.; Lu, K. P. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 2002, 277, 47976-47979.
48. Zheng, H.; You, H.; Zhou, X. Z.; Murray, S. A.; Uchida, T.; Wulf, G.; Gu, L.; Tang, X.; Lu, K. P.; Xiao, Z. X. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419, 849-853.
49. Mantovani, F.; Piazza, S.; Gostissa, M.; Strano, S.; Zacchi, P.; Mantovani, R.; Blandino, G.; Del Sal, G. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 2004, 14, 625-636.
50. De Nicola, F.; Bruno, T.; Iezzi, S.; Di Padova, M.; Floridi, A.; Passananti, C.; Del Sal, G.; Fanciulli, M. The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage. J. Biol. Chem. 2007, 282, 19685-19691.
51. Pinton, P.; Rimessi, A.; Marchi, S.; Orsini, F.; Migliaccio, E.; Giorgio, M.; Contursi, C.; Minucci, S.; Mantovani, F.; Wieckowski, M. R.; Del Sal, G.; Pelicci, P. G.; Rizzuto, R. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007, 315, 659-663.
52. Sultana, R.; Boyd-Kimball, D.; Poon, H. F.; Cai, J.; Pierce, W. M.; Klein, J. B.; Markesbery, W. R.; Zhou, X. Z.; Lu, K. P.; Butterfield, D. A. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol. Aging 2006, 27, 918-925.
53. Lu, K. P.; Zhou, X. Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signaling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8, 904-916.
54. Pang, R.; Lee, T. K.; Poon, R. T.; Fan, S. T.; Wong, K. B.; Kwong, Y. L.; Tse, E. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 2007, 132, 1088-1103.
55. Zhao, Y.; Chen, Y.; Schutkowski, M.; Fischer, G.; Ke, H. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 1997, 5, 139-146.
56. Jacobs, D. M.; Saxena, K.; Vogtherr, M.; Bernado, P.; Pons, M.; Fiebig, K. M. Peptide binding induces large scale changes in inter-domain mobility in human Pin1. J. Biol. Chem. 2003, 278, 26174-26182.
57. Eckerdt, F.; Yuan, J.; Saxena, K.; Martin, B.; Kappel, S.; Lindenau, C.; Kramer, A.; Naumann, S.; Daum, S.; Fischer, G.; Dikic, I.; Kaufmann, M.; Strebhardt, K. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J. Biol. Chem. 2005, 280, 36575-36583.
58. Butterfield, D. A.; Poon, H. F.; St Clair, D.; Keller, J. N.; Pierce, W. M.; Klein, J. B.; Markesbery, W. R. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol. Dis. 2006, 22, 223-232.
59. Butterfield, D. A.; Abdul, H. M.; Opii, W.; Newman, S. F.; Joshi, G.; Ansari, M. A.; Sultana, R. Pin1 in Alzheimer's disease. J. Neurochem. 2006, 98, 1697-1706.
60. Ryo, A.; Uemura, H.; Ishiguro, H.; Saitoh, T.; Yamaguchi, A.; Perrem, K.; Kubota, Y.; Lu, K. P.; Aoki, I. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 2005, 11, 7523-7531.
61. Wang, X. J.; Etzkorn, F. A. Peptidyl-prolyl isomerase inhibitors. Biopolymers 2006, 84, 125-146.
62. Hennig, L.; Christner, C.; Kipping, M.; Schelbert, B.; Rücknagel, K. P.; Grabley, S.; Küllertz, G.; Fischer, G. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 1998, 37, 5953-5960.
63. Chao, S. H.; Greenleaf, A. L.; Price, D. H. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 2001, 29, 767-773.
64. Uchida, T.; Takamiya, M.; Takahashi, M.; Miyashita, H.; Ikeda, H.; Terada, T.; Matsuo, Y.; Shirouzu, M.; Yokoyama, S.; Fujimori, F.; Hunter, T. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem. Biol. 2003, 10, 15-24.
65. Wang, X. J.; Hart, S. A.; Xu, B.; Mason, M. D.; Goodell, J. R.; Etzkorn, F. A. Serine-cis-proline and serine-trans-proline isosteres: stereoselective synthesis of (Z)- and (E)-alkene mimics by Still-Wittig and Ireland-Claisen rearrangements. J. Org. Chem. 2003, 68, 2343-2349.
66. Wang, X. J.; Xu, B.; Mullins, A. B.; Neiler, F. K.; Etzkorn, F. A. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. J. Am. Chem. Soc. 2004, 126, 15533-15542.
67. Zhang, Y.; Fussel, S.; Reimer, U.; Schutkowski, M.; Fischer, G. Substrate-based design of reversible Pin1 inhibitors. Biochemistry 2002, 41, 11868-11877.
68. Zhang, Y.; Daum, S.; Wildemann, D.; Zhou, X. Z.; Verdecia, M. A.; Bowman, M. E.; Lücke, C.; Hunter, T.; Lu, K. P.; Fischer, G.; Noel, J. P. Structural basis for high-affinity peptide inhibition of human Pin1. ACS Chem. Biol. 2007, 2, 320-328.
69. Wildemann, D. Erdmann, F.; Alvarez, B. H.; Stoller, G.; Zhou, X. Z.; Fanghänel, J.; Schutkowski, M.; Lu, K. P.; Fischer, G. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. J. Med. Chem. 2006, 49, 2147-2150.